Home Health B.C. doctors call for better access to ‘special authority’ drugs, including for diabetics

B.C. doctors call for better access to ‘special authority’ drugs, including for diabetics

by News Desk
0 comment

Two B.C. doctors are calling for greater access to a range of potentially life-saving medicines that are only covered by public health care under certain circumstances.

For example, Ozempic, touted as a breakthrough drug for people with type 2 diabetes, is on the state’s list of “special authority” drugs. Not regularly covered by full coverage, but may be approved by BC. Pharma care A special authority team at the request of the patient’s attending physician.

However, for its approval, patients must first have run out of dual therapy with metformin and insulin or metformin and sulfonylureas.

read more:

‘Preparing for transformation’: Waiting for BC cancer surgery leaves time for nurse’s tumor to grow

Dr. Ari Zentner, an expert in internal medicine, diabetes and obesity, told Global News:

The story continues under the ad

“In British Columbia, patients must decline an older, less effective drug, in this case a more dangerous drug, in order to receive coverage for the new drug.”


Click to play video: 'Experts warn longer wait times for emergency rooms in BC'


Experts warn of longer wait times coming to BC emergency rooms


According to the Ministry of Health, special authorization list drugs such as Ozempic, or devices such as glucose monitors, are either effective only in certain patients or are “less cost-effective than other drug treatments and devices” and cannot be automated. generally not subject to BC. “

The decision to provide coverage is also informed by the evidence-based recommendations of the independent BC Drug Benefit Council. The panel will review patient opinions, ethical considerations, clinical and economic evidence, the ministry added.

“These are decisions made by BC PharmaCare and its clinical team. We clearly see the evidence,” Health Minister Adrian Dix told parliament on Tuesday.

The story continues under the ad

“This is how the system works most efficiently and we can orient it towards the clinical team.”

read more:

Federal Plan to Improve Access to Diabetes Care Introduced in House

Ozempic, or semaglutide, is a weekly injection. According to its websiteIt helps the pancreas to produce more insulin when blood sugar levels are high, prevents the liver from producing or releasing too much sugar, and slows food out of the stomach.

Colin Taylor, a Vancouver patient, has been on the drug for about two years, where it helped lower his blood sugar levels and contributed to a weight loss of over 50 pounds.

“It’s just a quick injection as opposed to taking a pill every morning and every night,” he told Global News.

“It made me more active and slimmer…it should be available to everyone.”


Click to play video: 'Health Issues: High Prevalence of Iron Deficiency in Pregnant Women and Access to Diabetes Medications'


Health issues: high iron deficiency rates among pregnant women and high access to diabetes medications


BCDiabetes medical director Tom Elliott, PhD, has about 3,000 people with type 2 diabetes, half of whom are on Ozempic. Of that half, about 30% have expanded their health insurance coverage, he added.

The story continues under the ad

“1,500 of my patients are left insolvent because they cannot afford it or have no insurance,” he said.

“I have the right to decide who should receive it and who should not. What are PharmaCare pharmacists qualified to do?”

read more:

Changes to BC Self-Isolation Requirements Receive Mixed Reviews

Elliott expressed concern over one of the courses of treatment PharmaCare would need before Ozempic was considered, saying that glyburide (classified in the sulfonylurea class of drugs) had “dangerous” side effects, including hypoglycemia. I pointed out that it can cause

“I’m not going to write a prescription for glyburide to meet Pharmacare’s requirements. The policies they have are bad,” he said.

“There is now a class of drugs that are not only superior in terms of hypoglycemic effects, but also have cardiovascular benefits and do not cause hypoglycemia. Why not prescribe these drugs first?” Zentner Added.

“For example, I’m still rejected even when we’re following their protocol.”


Click to play video:


Health Issues: The Role of Testosterone in Men’s Health


Zentner says the current system either requires doctors to “follow” a series of “old-fashioned, inappropriate and dangerous guidelines” or patients actually run out of one of PharmaCare’s required courses of treatment first. It encourages people to lie for the sake of others.

The story continues under the ad

Dix said BC is reviewing “clinical evidence” about whether Ozempic and other drugs qualify for first-line or second-line coverage in the state, and “some action will be taken soon.” I hope that it will be taken.”

The Department of Health said it has a “rigorous and transparent” drug review process and offers “one of the most generous drug compensation programs” of any Canadian province.

© 2022 Global News, a division of Corus Entertainment Inc.

You may also like

Leave a Comment

Copyright ©️ All rights reserved. | Canadian Trends